Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Disease Patients
-
- STATUS
- Not Recruiting
-
- participants needed
- 480
-
- sponsor
- Xuanwu Hospital, Beijing
Updated on 22 July 2024
Summary
The purpose of this study is to determine whether Green Tea Polyphenol, an extraction from Green Tea is effective and safe in the treatment of De Novo Parkinson's disease Patients without taking any antiparkinsonism drug
Description
The primary outcome measurement is UPDRS using a delay start design. Total 480 de novo PD patients divided into three dosage groups of green tea polyphenol and one placebo control group. Patients will be treated for one year.
Details
| Condition | Parkinson's Disease |
|---|---|
| Age | 30years or above |
| Treatment | Green Tea Polyphenols (EGCG/ECG) |
| Clinical Study Identifier | NCT00461942 |
| Sponsor | Xuanwu Hospital, Beijing |
| Last Modified on | 22 July 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.